⚠️
Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Joint range of motion decreased
6,509 total reports2.9% serious outcomes
Share
6,509
Total Reports
3
Deaths
187
Hospitalizations
2.9
Severity Rate
% serious outcomes
About Joint range of motion decreased Reports
Joint range of motion decreased has been reported 6,509 times in VAERS from 1990 to 2026.
Of these reports, 3 were associated with death (0.05%) and 187 involved hospitalization.
The overall serious outcome rate (death or hospitalization) for reports mentioning Joint range of motion decreased is 2.9%.
Understanding Joint range of motion decreased in VAERS
•Temporal association only: These reports show Joint range of motion decreased occurred after vaccination, not necessarily because of vaccination.
•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.
•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.
•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.
What This Data Shows
Most Associated Vaccines: The vaccines most frequently mentioned in reports with Joint range of motion decreased. This may reflect usage patterns, not causation.
Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.
Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.
Most Associated Vaccines
1. COVID192,767
2. FLU31,267
3. FLU4791
4. PPV691
5. FLUX539
6. TDAP434
7. VARZOS346
8. TD177
9. UNK112
10. FLUC4106
Quick Facts
Reports:6,509
Deaths:3
Hospitalizations:187
Mortality Rate:0.05%
Severity Rate:2.9%
Related Analysis
Explore Further
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.